All roads lead to mitosis: A common requirement for DNA replication stress-dependent and -independent killing of

Sebastian Omar Siri1, Ariel Abramovici Blasco1, Ginette Moyano1

  • 1Cell Cycle and Genome Stability Laboratory, Fundación Instituto Leloir, Buenos Aires C1405 BWE, Argentina; Instituto de Investigaciones Bioquímicas de Buenos Aires (IIBBA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires C1405 BWE, Argentina.

Insights

Targeting BRCA1/2-deficient tumors with PARP inhibitors (PARPi) can lead to resistance. This review explores alternative treatments, including ROCK and PLK1 inhibitors, that may overcome resistance by inducing cell death independently of replication stress or chromosome instability.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • BRCA1 and BRCA2 (Breast cancer genes 1 and 2) mutations lead to early-onset tumors.
  • Poly (ADP-ribose) polymerase inhibitors (PARPi) selectively target BRCA1/2-deficient tumors but can cause treatment resistance.
  • PARPi induce cell death via replication stress and chromosome instability, including micronuclei accumulation.

Purpose of the Study:

  • To review alternative therapeutic strategies for BRCA1/2-deficient tumors.
  • To identify treatments that selectively kill cancer cells while minimizing side effects.
  • To explore mechanisms of cell death that circumvent PARPi resistance.

Main Methods:

  • Literature review of existing and emerging cancer therapies.
  • Analysis of treatment-induced cell death pathways in BRCA1/2-deficient models.
  • Comparison of replication stress-dependent and -independent cell killing mechanisms.

Main Results:

  • PARPi efficacy is linked to replication stress and chromosome instability.
  • Alternative treatments are being investigated for BRCA1/2-deficient tumors.
  • Rho-kinase (ROCK) and Polo-like kinase 1 (PLK1) inhibitors show potential for RS-independent, MN-independent cell killing.

Conclusions:

  • Alternative therapies targeting ROCK and PLK1 may offer novel strategies against BRCA1/2-deficient tumors.
  • RS-independent and MN-independent cell killing mechanisms could prevent or delay treatment resistance.
  • Targeting distinct cell death pathways may overcome limitations of current PARPi treatments.

Related Concept Videos

The DNA Replication Fork01:02

The DNA Replication Fork

An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork.   Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication...
36.8K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.9K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
52.0K
DNA Damage Can Stall the Cell Cycle02:37

DNA Damage Can Stall the Cell Cycle

2.7K
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
4.8K